The Technical Analyst
Select Language :
Crinetics Pharmaceuticals [CRNX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Crinetics Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Crinetics Pharmaceuticals is listed at the  Exchange

5.36% $46.81

America/New_York / 28 mar 2024 @ 16:00


Crinetics Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3 647.88 mill
EPS: -3.69
P/E: -12.69
Earnings Date: May 02, 2024
SharesOutstanding: 77.93 mill
Avg Daily Volume: 0.750 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -12.69 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-2.16x
Company: PE -12.69 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-5.32
(-111.36%) $-52.13
Date: 2024-03-28
Expected Trading Range (DAY)

$ 44.28 - 49.35

( +/- 5.42%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-22 Knight Jeff E. Sell 30 000 Stock Option (right to buy)
2024-03-22 Knight Jeff E. Buy 30 000 Common Stock
2024-03-22 Knight Jeff E. Sell 30 000 Common Stock
2024-03-22 Knight Jeff E. Sell 2 359 Common Stock
2024-03-20 Pizzuti Dana Sell 4 375 Stock Option (right to buy)
INSIDER POWER
25.93
Last 99 transactions
Buy: 1 520 833 | Sell: 975 029

Forecast: 16:00 - $46.71

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $46.71
Forecast 2: 16:00 - $46.71
Forecast 3: 16:00 - $46.71
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $46.81 (5.36% )
Volume 1.289 mill
Avg. Vol. 0.750 mill
% of Avg. Vol 171.93 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Crinetics Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Crinetics Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Crinetics Pharmaceuticals Inc

Last 10 Buy & Sell Signals For CRNX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$38.53N/AActive
Profile picture for
            Crinetics Pharmaceuticals Inc

CRNX

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
PROPCUSDMar 29 - 00:395.17
TUSDUSDMar 29 - 00:35$0.996
UQCUSDMar 29 - 00:34$9.10
USDTUSDMar 29 - 00:27$1.000
FIDAUSDMar 29 - 00:18$0.533
XFUNDUSDMar 29 - 00:18658.80
BNTUSDMar 29 - 00:15$0.879
GTCUSDMar 29 - 00:142.14
RIOUSDMar 29 - 00:092.48
DEGOUSDMar 29 - 00:083.86

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.